The Process of Stem Cells

What is Adult Stem Cell Research and What Are its Applications for Healing?

One of the most exciting breakthroughs in biotechnology in recent years is the use of one's own blood born stem cells to repair one's heart. Taken from the patient suffering from end-stage heart disease, the process of stem cells and how they repair the heart is fascinating. Removed from the patient in a normal blood donor type of procedure, the patient's stem cells are derived from the blood, cultivated in a lab within 5 days into several tens of millions of synergetic cells of the patient, then injected into the patient by a qualified physician. Upon reinjection, the synergetic cells go to work to repair the damaged heart or save a limb from amputation (in the case of peripheral artery disease).

"The body is programmed to heal itself using all of its own intelligence," said David Reese, President & CEO of TheraVitae, a global company that produces both a heart repair and peripheral vascular repair stem cell therapy. "Acting as neovascular plumbers, VesCell/your stem cells recognize the body's natural signalling mechanisms and leverage it to recruit other synergetic cells to the site in need of repair. There they regenerate blood flow and function...we witness revascularization of limbs which would otherwise require amputation in over 95 per cent of the PAD cases treated," he said.

Since, in the case of VesCell treatment, the stem cells are the patient's own, they use the body's natural regulating processes, migrate to the site of need, engraft at the site of need, build neovascularization, and recruit other circulating stem cells to the task of regeneration of blood flow and function.

Safe, Simple and Effective Healing Done by Your Own Body

VesCell adult stem cell therapy has been shown to dramatically improve the quality of life for people suffering heart disease or peripheral artery disease. The safe, simple and effective process of stem cells taken from adults and reintroduced into their bodies takes place in hospital treatment centers located in Bangkok, Thailand, Singapore, and the Dominican Republic.

The Results of Congestive Heart Failure Stem Cell Research

Years of research and clinical trials have resulted in TheraVitae's successful adult stem cell therapy. It is used to treat congestive heart failure, idiopathic and non idiopathic cardiomyopathy, angina, and other forms of heart and artery diseases. In as little as one month after treatment, patients experience an improvement in their quality of life; after three months, approximately 75% of patients can, again, enjoy activities once restricted by their illness. Once recovered, TheraVitae patients show substantial improvement. Many become patient volunteers to help educate others afflicted with end-stage heart disease.

Although VesCell™ stem cell therapy is currently used only to treat heart disease and peripheral artery disease (PAD), the revolutionary treatment is believed to also have the potential to cure or mitigate many other degenerative diseases. "We have unlocked the body's operating system," said David Reese. "We are able to differentiate the patient's blood born stem cells into cardiomyocytes - heart-like cells - angiogenic cell precursors which create neovascularization and regenerate heart function and blood flow to extremities, and neuronal cell precursors. All have a demonstrated ability to home to the site of need", he said. "Our best evidence is the hundreds of treated patients. One of our most prolific cases is a patient who had a heart twice the size of normal after 11 heart attacks, and an ejection fraction in the low teens. After three treatments over three years, his ejection fraction is 47%," said Mr. Reese.

Advantages of Using Adult Stem Cells from Patient's Blood

There are several advantages to the process of stem cells isolated from an adult's blood:

There are no ethical considerations because these stem cells can be harvested from the blood of the treated patient.

Taking a blood sample is significantly easier and less invasive to the patient than harvesting from bone marrow.

There is no chance of rejection of the cells by the body.

Storage of harvested cells is not an issue.

Adult stem cells isolated from blood can be prompted to multiply in vitro.

TheraVitae has been recognized by the World Economic Forum as a biotechnology pioneer, and TheraVitae's clinical trial results and science are published in the Asian Cardiovascular & Thoracic Annals (PDF) (2008, Vol. 16, No. 2) and the British Journal of Haematology.

If you’d like to know more about VesCell adult stem cell therapy to address your heart disease or late-stage peripheral arterial disease, please contact Jerry@VesCell.com, or dial 1-888-410-0902, or take a minute now to fill out our inquiry form. Upon receipt, a TheraVitae patient care coordinator will contact you.